These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 29890221

  • 1. Misfolded rhodopsin mutants display variable aggregation properties.
    Gragg M, Park PS.
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2938-2948. PubMed ID: 29890221
    [Abstract] [Full Text] [Related]

  • 2. Detection of misfolded rhodopsin aggregates in cells by Förster resonance energy transfer.
    Gragg M, Park PS.
    Methods Cell Biol; 2019 Sep; 149():87-105. PubMed ID: 30616829
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Misfolded opsin mutants display elevated β-sheet structure.
    Miller LM, Gragg M, Kim TG, Park PS.
    FEBS Lett; 2015 Oct 07; 589(20 Pt B):3119-25. PubMed ID: 26358292
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of rhodopsin retinitis pigmentosa and the efficacy of pharmacological rescue.
    Krebs MP, Holden DC, Joshi P, Clark CL, Lee AH, Kaushal S.
    J Mol Biol; 2010 Feb 05; 395(5):1063-78. PubMed ID: 19913029
    [Abstract] [Full Text] [Related]

  • 6. Retinitis pigmentosa mutants provide insight into the role of the N-terminal cap in rhodopsin folding, structure, and function.
    Opefi CA, South K, Reynolds CA, Smith SO, Reeves PJ.
    J Biol Chem; 2013 Nov 22; 288(47):33912-33926. PubMed ID: 24106275
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Structural development study of a novel pharmacological chaperone for folding-defective rhodopsin mutants responsible for retinitis pigmentosa].
    Ohgane K, Dodo K, Hashimoto Y.
    Yakugaku Zasshi; 2011 Mar 22; 131(3):325-34. PubMed ID: 21372525
    [Abstract] [Full Text] [Related]

  • 10. Calnexin improves the folding efficiency of mutant rhodopsin in the presence of pharmacological chaperone 11-cis-retinal.
    Noorwez SM, Sama RR, Kaushal S.
    J Biol Chem; 2009 Nov 27; 284(48):33333-42. PubMed ID: 19801547
    [Abstract] [Full Text] [Related]

  • 11. Aggregation of rhodopsin mutants in mouse models of autosomal dominant retinitis pigmentosa.
    Vasudevan S, Senapati S, Pendergast M, Park PS.
    Nat Commun; 2024 Feb 16; 15(1):1451. PubMed ID: 38365903
    [Abstract] [Full Text] [Related]

  • 12. Wild-type opsin does not aggregate with a misfolded opsin mutant.
    Gragg M, Kim TG, Howell S, Park PS.
    Biochim Biophys Acta; 2016 Aug 16; 1858(8):1850-9. PubMed ID: 27117643
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structure and function in rhodopsin: packing of the helices in the transmembrane domain and folding to a tertiary structure in the intradiscal domain are coupled.
    Hwa J, Garriga P, Liu X, Khorana HG.
    Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):10571-6. PubMed ID: 9380676
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacological manipulation of rhodopsin retinitis pigmentosa.
    Mendes HF, Zaccarini R, Cheetham ME.
    Adv Exp Med Biol; 2010 Sep 30; 664():317-23. PubMed ID: 20238031
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa.
    Kaushal S, Khorana HG.
    Biochemistry; 1994 May 24; 33(20):6121-8. PubMed ID: 8193125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.